Inventor · disambiguated record
Mark Ridall
Also filed as: RIDALL MARK
12 granted patents·11 pending applications·68 citations·filing 2012–2024
91Inventor score
Files withORCOSA INC11NEWMARKET PHARMACEUTICALS LLC9NEW MARKET PHARMACEUTICALS1NEW MARKET PHARMACEUTICALS LLC1ROCK DAVID1
Top patents by PatentIndex Score
23 records- 0195US12496295B2Veterinary pharmaceutical compositions for direct systemic introductionNEWMARKET PHARMACEUTICALS LLC·Filed 2024·Granted Dec 16, 2025·3 cites·16 claims
- 0295US10918631B2Pharmaceutical compositions for direct systemic introductionNEWMARKET PHARMACEUTICALS LLC·Filed 2020·Granted Feb 16, 2021·4 cites·25 claims
- 0394US12005053B2Veterinary pharmaceutical compositions for direct systemic introductionNEWMARKET PHARMACEUTICALS LLC·Filed 2021·Granted Jun 11, 2024·3 cites·19 claims
- 0494US10695332B2Pharmaceutical compositions for direct systemic introductionNEWMARKET PHARMACEUTICALS LLC·Filed 2018·Granted Jun 30, 2020·8 cites·17 claims
- 0591US11166945B2Animal treatmentsNEWMARKET PHARMACEUTICALS LLC·Filed 2020·Granted Nov 9, 2021·2 cites·21 claims
- 0689US10702509B2Animal treatmentsNEW MARKET PHARMACEUTICALS LLC·Filed 2018·Granted Jul 7, 2020·5 cites·11 claims
- 0789US10022361B2Animal treatmentsNEWMARKET PHARMACEUTICALS LLC·Filed 2014·Granted Jul 17, 2018·9 cites·9 claims
- 0888US10064849B2Pharmaceutical compositions for direct systemic introductionNEW MARKET PHARMACEUTICALS·Filed 2012·Granted Sep 4, 2018·14 cites·15 claims
- 0988US9402835B2Animal treatmentsNEWMARKET PHARMACEUTICALS LLC·Filed 2014·Granted Aug 2, 2016·8 cites·4 claims
- 1087US11672761B2Rapidly infusing platform and compositions for therapeutic treatment in humansORCOSA INC·Filed 2021·Granted Jun 13, 2023·4 cites·33 claims
- 1186US2024091211A1Animal treatmentsNEWMARKET PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1284US8722636B2Animal treatmentsROCK DAVID·Filed 2012·Granted May 13, 2014·8 cites·4 claims
- 1379US11844789B2Animal treatmentsNEWMARKET PHARMACEUTICALS LLC·Filed 2021·Granted Dec 19, 2023·0 cites·20 claims
- 1473US2024009133A1Methods of treating autoimmune or inflammatory conditions with cannabidiol or its derivatives/analogsORCOSA INC·Filed 2021·Application pending·0 cites
- 1573US2023414519A1Rapidly infusing compositions with methotrexate and treatment methodsORCOSA INC·Filed 2021·Application pending·0 cites
- 1672US2024009132A1Cannabinoids in the treatment of autism spectrum disorderORCOSA INC·Filed 2021·Application pending·0 cites
- 1772US2024000808A1Improved use of cannabinoids in the treatment of alzheimer's diseaseORCOSA INC·Filed 2021·Application pending·0 cites
- 1872US2024000809A1Improved use of cannabinoids in the treatment of epilepsyORCOSA INC·Filed 2021·Application pending·0 cites
- 1970US2023404915A1RAPIDLY DISINTERGRATING COMPOSTIONS AND METHODS (Nicotine)ORCOSA INC·Filed 2021·Application pending·0 cites
- 2070US2024009130A1Rapidly infusing compositions for oral mucosal delivery and methodsORCOSA INC·Filed 2021·Application pending·0 cites
- 2163US2023285303A1Rapidly infusing platform and compositions for therapeutic treatment in humansORCOSA INC·Filed 2023·Application pending·0 cites
- 2257US2024000810A1Use of cannabinoids in the treatment of tourette syndrome and tic disordersORCOSA INC·Filed 2023·Application pending·0 cites
- 2357US2023372370A1Use of cannabinoids in the treatment of covid-19ORCOSA INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Ridall files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →